DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Business Affairs Homepage

Driving premium platform valuations for future growth The radiology M&A market is red hot, help investors see the value in your business

Daniel Kelsey AHRA hires chief executive officer

TIAA Bank acquires $1.5 billion portfolio from GE Capital's HEF business Portfolio of healthcare equipment leases and loans

Robert Sledd Owens & Minor names board member, chairman and interim president and CEO

Clinical wearables – remaining competitive in an evolving market Insights from Ravi Kuppuraj, Business Leader of Connected Sensing Venture for Philips

Veritas Capital, Evergreen Coast Capital to take athenahealth for $5.7 billion Gives athenahealth stock holders $135 in cash per share

A look into the medical device design process Go behind the scenes to see what factors contribute to the design of new medical devices

How hassle maps can improve radiology department operations Tips for finding and addressing friction points and improving overall patient care in radiology

Dr. Jonathan Luchs Premier Radiology Services appoints chief medical officer

When radiologists speak up, follow-up imaging improves Study supports better communication between radiologists and referring clinicians

Hologic has acquired Faxitron Bioptics
for $85 million

Hologic acquires Faxitron Bioptics for $85 million

by John R. Fischer , Staff Reporter
Hologic Inc. has acquired Faxitron Bioptics for approximately $85 million, expanding its product portfolio within the breast conservation surgical market.

The purchase of the privately held enterprise gives Hologic access to Faxitron solutions, designed for breast lesion localization and sentinel lymph node biopsy, as well as digital specimen radiography.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

“With the expanding range of Hologic's breast health portfolio, this acquisition further strengthens our ability to positively impact patient lives by enabling us to play a larger role in breast conserving surgery, an adjacent growth market for the company's interventional breast business,” Pete Valenti, division president of Hologic’s breast and skeletal health solutions, told HCB News.

Earlier this week, Hologic scored a victory in a Delaware federal court against Minerva Surgical which it sued for patent infringement over its NovaSure Endometrial Ablation System. The court awarded the women’s health technology company $4.8 million in damages, including lost profits and $587,000 for lost sales royalties of eight percent.

The acquisition is also the second time that Faxitron has made headlines in recent weeks, having just last month merged its irradiation business with that of Precision X-ray into a new company, DRMC X-ray, which carries an installed base of more than 1,000 systems and is expected by both Faxitron and PXi to become a global leader in biological irradiation.

The agreement equips Hologic with a variety of solutions including Faxitron’s VisionCT, the first 3D breast specimen-designated CT systems designed and FDA approved to offer 360-degree images of excised lesions, and its VersaVision digital specimen radiography system, cleared in October by the FDA for imaging core biopsy and surgically excised specimen samples.

Its decision to acquire Faxitron, according to Valenti, stemmed from a shared view on innovation in breast cancer diagnostics and treatment as well as the Science of Sure approach held by Hologic to produce quality clinical results that enable early identification of symptoms, greater diagnostic confidence and compassionate treatment of patients.

“With this acquisition, Hologic can now offer our customers an increasingly comprehensive portfolio of products that offer a broad range of solutions at multiple clinical call-points including radiology, surgery and pathology,” he said.

Primarily a provider for breast surgeons and pathologists, Faxitron racked up approximately $27 million in revenue in its last fiscal year. The company's employees will not be negatively impacted by the sale, according to Hologic.

The acquisition is expected to be roughly neutral to Hologic’s non-GAAP earnings per share for the rest of fiscal 2018 and 2019, after which, it is expected to be accretive, attracting growth and return on invested capital.

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.